Melanie Broll

Paratriathlete Anja Renner openly shares her life with RP and her experiences with OkuStim® therapy – honest, relatable, encouraging.

Fair conditions without special privileges: How to apply for adjustments and implement them practically.

Alfred Stett on the journey from neurostimulation to evidence-based care—and what drives Okuvision.

Former pilot Reinhard stabilizes his condition with TES – with routine and confidence.

Ines has relied on TES for years – active in her studies, sport, and everyday life.

Living with RP for decades, using TES since 2019: Haap relies on structure, support, and optimism. He reports noticeable changes in his daily life.

Caterina has been using TES for three years and speaks openly about challenges, routine, and impact.

From Booking to Boarding – reach your destination relaxed with planning, assistance, and orientation aids.

Why RP is a burden – and what is proven to help: education, support, rehab, and preservation of function. With concrete strategies for everyday life.

Independent, individual, and accessible: EUTB® supports you – including with cost coverage applications for OkuStim® therapy.

The LSG Lower Saxony-Bremen considers impending blindness in Retinitis pigmentosa (RP) to be an emergency-like situation and obliges a health insurance company to retroactively reimburse the OkuStim®…

Concise, clear, evidence-based: We dispel false expectations and show what is possible today.

Go in well-prepared, come out clearly informed: This checklist helps you understand findings and together take informed decisions.

DOG, RG, and BVA name electrostimulation as a therapy option for Retinitis pigmentosa and refer to the G-BA trial study.